RXST as of Nov 2 · 12:40 ET
RXSTNasdaqOphthalmic Goods

RxSight, Inc. · Brief

Next report

2 days

Nov 4 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
1 of 7≥ implied
avg implied
±33.9%
avg realized
±11.0%
Jul 8 '25±11.3%▼−37.84%×3.35
Aug 7 '25±13.4%▼−7.70%×0.57
Nov 5 '25±57.1%▲+3.24%×0.06
Jan 12 '26±16.4%▲+0.20%×0.01
Q1 FY26±25.6%▼−10.10%×0.39
May 6 '26±62.1%▼−14.45%×0.23
Q2 FY26—▲+0.36%—
Aug 5 '26±51.3%▼−3.34%×0.07
quarterimplied−65%0+65%realized×
Aug '26±51.3%▼−3.34%×0.07
Q2 FY26—▲+0.36%—
May '26±62.1%▼−14.45%×0.23
Q1 FY26±25.6%▼−10.10%×0.39
Jan '26±16.4%▲+0.20%×0.01
Nov '25±57.1%▲+3.24%×0.06
2 older reports
Aug '25±13.4%▼−7.70%×0.57
Jul '25±11.3%▼−37.84%×3.35
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2

+29.43%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
150managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

5 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
3tracked funds holding RXSTN-PORT · Aug 31 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

RXST report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±61.4% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.